Singing River Health System First in Mississippi to Offer HYDROS™ Robotic System: AI Powered Aquablation Therapy to Treat Enlarged Prostate

Singing River Health System is the first in Mississippi to offer Aquablation® therapy with the new HYDROS™ Robotic System, an AI-powered platform designed to treat benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. This cutting-edge treatment is now available exclusively at Singing River.

Dr. William Hughes of Urology Associates is the first urologist in Mississippi to perform Aquablation therapy using the HYDROS Robotic System with FirstAssist AI™ technology.

BPH affects millions of men, causing obstructive symptoms, frequent urination, urgency, and incomplete bladder emptying. Without timely treatment, BPH can lead to severe health issues such as permanent bladder or kidney damage, bladder stones, urinary tract infections, and incontinence. While surgery has been the standard treatment, it often comes with risks to sexual function and continence.

“As the first urologist in Mississippi to perform Aquablation therapy with the HYDROS Robotic System, I’m proud to bring this advanced, minimally invasive treatment to patients,” said Dr. Hughes, who is performing the procedure at Singing River Gulfport. “Aquablation therapy allows for a higher level of precision and has been proven to provide long-lasting relief while preserving sexual function and quality of life—benefits not always possible with traditional treatments.”

Aquablation therapy is a minimally invasive robotic-assisted procedure that uses real-time ultrasound guidance and a heat-free waterjet to precisely remove excess prostate tissue while protecting critical anatomy. The HYDROS system enhances efficiency, accuracy, and outcomes by leveraging insights from over 50,000 procedures. Backed by five-year clinical data, it offers significant, durable symptom relief and a high rate of patient satisfaction.